Compare CDXS & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDXS | CFFI |
|---|---|---|
| Founded | 2002 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 298.3M |
| IPO Year | 2008 | 1996 |
| Metric | CDXS | CFFI |
|---|---|---|
| Price | $1.32 | $93.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 732.5K | 58.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | ★ 43.82 | 37.94 |
| EPS | N/A | ★ 4.71 |
| Revenue | $138,590,000.00 | ★ $140,841,000.00 |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | ★ N/A | $19.75 |
| Revenue Growth | ★ 32.30 | 10.63 |
| 52 Week Low | $0.96 | $65.39 |
| 52 Week High | $2.98 | $97.07 |
| Indicator | CDXS | CFFI |
|---|---|---|
| Relative Strength Index (RSI) | 36.21 | 57.89 |
| Support Level | $1.25 | $69.33 |
| Resistance Level | $1.76 | $97.07 |
| Average True Range (ATR) | 0.08 | 2.36 |
| MACD | 0.00 | -0.46 |
| Stochastic Oscillator | 28.26 | 55.94 |
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.